Tokyo Tape
Sign in
← Santen Pharmaceutical

Annual report

4536.TEDINET S100OEK1
Period2021-04-01 → 2022-03-31
Filed2022-06-24
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥266.3bn2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥249.6bn2020-04-01 → 2021-03-31Cons.Revenue IFRS
Revenue¥241.6bn2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥234.0bn2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥224.9bn2017-04-01 → 2018-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥35.9bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Operating income¥12.2bn2020-04-01 → 2021-03-31Cons.Operating profit loss IFRS
Profit before tax¥35.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥11.7bn2020-04-01 → 2021-03-31Cons.Profit loss before tax IFRS
Profit before tax¥32.1bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥43.1bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥39.3bn2017-04-01 → 2018-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥27.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥9.3bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥23.6bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥32.0bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥35.2bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥27.2bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Net income¥9.1bn2020-04-01 → 2021-03-31Cons.Profit loss IFRS
Total assets¥460.0bnat 2022-03-31Cons.Assets IFRS
Total assets¥405.3bnat 2021-03-31Cons.Assets IFRS
Total assets¥408.8bnat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥391.2bnat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥388.5bnat 2018-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥123.1bnat 2022-03-31Cons.Liabilities IFRS
Total liabilities¥95.6bnat 2021-03-31Cons.Liabilities IFRS
Net assets / equity¥336.8bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥309.6bnat 2021-03-31Cons.Equity IFRS
Net assets / equity¥302.6bnat 2020-03-31dCons.Equity IFRS
Equity (owners)¥337.5bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥310.2bnat 2021-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥302.9bnat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥290.9bnat 2019-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥285.8bnat 2018-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥83.0bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥62.9bnat 2021-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥91.4bnat 2020-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥70.8bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥69.3bnat 2018-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥46.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥38.8bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥39.9bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥32.9bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥42.8bn2017-04-01 → 2018-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥35.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥53.4bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥5.2bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.9bn2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥8.3bn2017-04-01 → 2018-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow¥5.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥16.7bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥12.7bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥28.1bn2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥17.6bn2017-04-01 → 2018-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥68.072021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥23.32020-04-01 → 2021-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥59.162019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥78.672018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥86.732017-04-01 → 2018-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥67.972021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥23.262020-04-01 → 2021-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥59.012019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥78.432018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥86.422017-04-01 → 2018-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥843.6at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥776.16at 2021-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥758.5at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥728.97at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥702.54at 2018-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio73.4%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio76.5%at 2021-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.1%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.4%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio73.6%at 2018-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE8.4%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE3.0%2020-04-01 → 2021-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE8.0%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE11.1%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE13.0%2017-04-01 → 2018-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees4,315at 2022-03-31Cons.Number of employees
Employees4,229at 2021-03-31Cons.Number of employees
Employees4,108at 2020-03-31dCons.Number of employees
Employees4,073at 2019-03-31dCons.Number of employees
Employees3,805at 2018-03-31dCons.Number of employees
Revenue¥190.8bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥186.1bn2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥182.6bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥176.2bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥171.9bn2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥21.4bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income¥23.6bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥22.5bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥25.3bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income¥34.9bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥33.2bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥31.7bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥25.2bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥27.4bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥17.4bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥21.8bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income¥27.4bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥28.0bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥25.4bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥363.8bnat 2022-03-31StandaloneAssets
Total assets¥353.6bnat 2021-03-31StandaloneAssets
Total assets¥340.0bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥321.9bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥320.8bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥66.3bnat 2022-03-31StandaloneLiabilities
Total liabilities¥59.4bnat 2021-03-31StandaloneLiabilities
Net assets / equity¥297.5bnat 2022-03-31StandaloneNet assets
Net assets / equity¥294.2bnat 2021-03-31StandaloneNet assets
Net assets / equity¥283.5bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥265.4bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥265.8bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥37.6bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥24.7bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥43.592021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥54.442020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥68.632019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥68.962018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥62.582017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥43.532021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥54.332020-04-01 → 2021-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥68.462019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥68.762018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥62.362017-04-01 → 2018-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥322021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥282020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥272019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥262018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥262017-04-01 → 2018-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥742.3at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥734.61at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥708.12at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥662.95at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥650.84at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio81.7%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.1%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.2%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.2%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.5%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE5.9%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE7.5%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE10.0%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE10.6%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
ROE10.0%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued400,695,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued400,369,000at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued400,028,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued399,782,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued406,848,000at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees1,839at 2022-03-31StandaloneNumber of employees
Employees1,872at 2021-03-31StandaloneNumber of employees
Employees1,840at 2020-03-31dStandaloneNumber of employees
Employees1,812at 2019-03-31dStandaloneNumber of employees
Employees1,859at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 1,628
ItemContextValueUnit
Disposal of treasury stockCurrentYearDuration_NonConsolidatedMember213000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember－JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-2520000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-2520000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember-134000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember-2653000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember216000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember5929000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-2520000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-2520000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember-134000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember3276000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_TreasuryStockMember-718000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember288486000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember8636000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember8636000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember384000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember297507000000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember7795000000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember8122000000JPY
Provision for bonuses sgaPrior1YearDuration_NonConsolidatedMember1742000000JPY
Provision for bonuses sgaCurrentYearDuration_NonConsolidatedMember1913000000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember862000000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember799000000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember6629000000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember6658000000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember33068000000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember31350000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-06-24
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第110期（自　2021年４月１日　至　2022年３月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)参天製薬株式会社
Company name in english cover pageFilingDateInstantSANTEN PHARMACEUTICAL CO., LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長兼CEO　谷内　樹生
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)大阪府大阪市北区大深町４番20号
Telephone number address of registered headquarter cover pageFilingDateInstant06(4802)9322
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)Head of Accounting and Tax, Japan増田　裕人
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)大阪府大阪市北区大深町４番20号
Telephone number nearest place of contact cover pageFilingDateInstant06(4802)9322
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)Head of Accounting and Tax, Japan増田　裕人
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00949
Fund codeFilingDateInstant－
Security codeFilingDateInstant45360
Filer name in japaneseFilingDateInstant
Original text (Japanese)参天製薬株式会社
Filer name in englishFilingDateInstantSANTEN PHARMACEUTICAL CO., LTD.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass